theophylline has been researched along with rolofylline in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (55.56) | 18.2507 |
2000's | 1 (11.11) | 29.6817 |
2010's | 2 (22.22) | 24.3611 |
2020's | 1 (11.11) | 2.80 |
Authors | Studies |
---|---|
Ishii, A; Karasawa, A; Kawakita, T; Kubo, K; Mizumoto, H; Nonaka, H; Shimada, J; Suzuki, F | 1 |
Ishii, A; Nonaka, H; Shimada, J; Suzuki, F | 1 |
Jacobson, KA; van Galen, PJ; Williams, M | 1 |
El-Tayeb, A; Inamdar, GS; Li, W; Müller, CE; Scheiff, AB; Sudarsanam, V; Vasu, KK; Yerande, SG | 1 |
Doroż-Płonka, A; Drabczyńska, A; Handzlik, J; Hinz, S; Karcz, T; Kieć-Kononowicz, K; Latacz, G; Müller, CE; Schabikowski, J; Stanuch, K; Szymańska, E; Załuski, M | 1 |
Gaba, S; Gupta, GD; Monga, V; Patel, R; Saini, A; Singh, G | 1 |
McGee, DS; Nakanishi, K; Tan, P; Vinten-Johansen, J; Zhao, ZQ | 1 |
Brause, M; Delabar, U; Eckardt, KU; Gleiter, CH; Zebski, H | 1 |
El Nahas, AM; Fang, L; Haylor, JL; Morcos, SK; Oldroyd, SD; Yates, MS | 1 |
2 review(s) available for theophylline and rolofylline
Article | Year |
---|---|
Adenosine receptors: pharmacology, structure-activity relationships, and therapeutic potential.
Topics: Adenosine; Animals; Humans; Models, Chemical; Receptors, Purinergic; Second Messenger Systems; Structure-Activity Relationship | 1992 |
Adenosine receptor antagonists: Recent advances and therapeutic perspective.
Topics: Dose-Response Relationship, Drug; Humans; Molecular Structure; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Structure-Activity Relationship | 2022 |
7 other study(ies) available for theophylline and rolofylline
Article | Year |
---|---|
Adenosine A1 antagonists. 2. Structure-activity relationships on diuretic activities and protective effects against acute renal failure.
Topics: Acute Kidney Injury; Adenosine; Animals; Cations, Monovalent; Diuretics; Male; Potassium; Radioligand Assay; Rats; Rats, Inbred Strains; Receptors, Purinergic; Sodium; Structure-Activity Relationship; Xanthines | 1992 |
8-Polycycloalkyl-1,3-dipropylxanthines as potent and selective antagonists for A1-adenosine receptors.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Binding, Competitive; Cell Membrane; Corpus Striatum; Guinea Pigs; Humans; Molecular Conformation; Molecular Structure; Prosencephalon; Purinergic Antagonists; Rats; Receptors, Purinergic; Stereoisomerism; Structure-Activity Relationship; Xanthines | 1992 |
2-Amino-5-benzoyl-4-phenylthiazoles: Development of potent and selective adenosine A1 receptor antagonists.
Topics: Adenosine A1 Receptor Antagonists; Animals; Drug Design; Humans; Molecular Structure; Rats; Receptor, Adenosine A1; Stereoisomerism; Structure-Activity Relationship; Thiazoles | 2010 |
Tricyclic xanthine derivatives containing a basic substituent: adenosine receptor affinity and drug-related properties.
Topics: | 2018 |
A1 receptor mediated myocardial infarct size reduction by endogenous adenosine is exerted primarily during ischaemia.
Topics: Adenosine; Adrenergic alpha-1 Receptor Antagonists; Animals; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Phenylisopropyladenosine; Rabbits; Random Allocation; Receptors, Adrenergic, alpha-1; Theophylline; Xanthines | 1994 |
Evidence against a major role of adenosine in oxygen-dependent regulation of erythropoietin in rats.
Topics: Adenine; Adenosine; Adenosine Diphosphate; Animals; Antihypertensive Agents; Carbon Monoxide; Dipyridamole; Diuretics; Drug Synergism; Enzyme Inhibitors; Erythropoietin; Gene Expression; Hypoxia; Kidney; Male; Oxygen; Phenethylamines; Phosphodiesterase Inhibitors; Piperazines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Receptors, Purinergic P1; RNA, Messenger; Theophylline; Vasodilator Agents; Xanthines | 1997 |
Effects of adenosine receptor antagonists on the responses to contrast media in the isolated rat kidney.
Topics: Adenosine; Analysis of Variance; Animals; Contrast Media; Diatrizoate; Glomerular Filtration Rate; Kidney; Male; Perfusion; Phosphodiesterase Inhibitors; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Theophylline; Triiodobenzoic Acids; Xanthines | 2000 |